Literature DB >> 16989620

Antibody-dependent enhancement and vaccine development.

Sandra Thomas, Jade B Redfern, Brett A Lidbury, Suresh Mahalingam.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16989620     DOI: 10.1586/14760584.5.4.409

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  9 in total

1.  Flavitrack: an annotated database of flavivirus sequences.

Authors:  Milind Misra; Catherine H Schein
Journal:  Bioinformatics       Date:  2007-07-28       Impact factor: 6.937

2.  Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1.

Authors:  Yun Kenneth Kang; Sofija Andjelic; James M Binley; Emma T Crooks; Michael Franti; Sai Prasad N Iyer; Gerald P Donovan; Antu K Dey; Ping Zhu; Kenneth H Roux; Robert J Durso; Thomas F Parsons; Paul J Maddon; John P Moore; William C Olson
Journal:  Vaccine       Date:  2009-06-28       Impact factor: 3.641

3.  A phylogenetic analysis using full-length viral genomes of South American dengue serotype 3 in consecutive Venezuelan outbreaks reveals a novel NS5 mutation.

Authors:  D J Schmidt; B E Pickett; D Camacho; G Comach; K Xhaja; N J Lennon; K Rizzolo; N de Bosch; A Becerra; M L Nogueira; A Mondini; E V da Silva; P F Vasconcelos; J L Muñoz-Jordán; G A Santiago; R Ocazionez; L Gehrke; E J Lefkowitz; B W Birren; M R Henn; I Bosch
Journal:  Infect Genet Evol       Date:  2011-09-23       Impact factor: 3.342

Review 4.  Advances and challenges towards a vaccine against Chagas disease.

Authors:  Israel Quijano-Hernandez; Eric Dumonteil
Journal:  Hum Vaccin       Date:  2011-11-01

5.  Sculpting humoral immunity through dengue vaccination to enhance protective immunity.

Authors:  Wayne D Crill; Holly R Hughes; Nicole B Trainor; Brent S Davis; Matt T Whitney; Gwong-Jen J Chang
Journal:  Front Immunol       Date:  2012-11-08       Impact factor: 7.561

Review 6.  Dengue conundrums.

Authors:  Robert V Gibbons
Journal:  Int J Antimicrob Agents       Date:  2010-08-08       Impact factor: 5.283

Review 7.  Vaccines in development against West Nile virus.

Authors:  Samantha Brandler; Frederic Tangy
Journal:  Viruses       Date:  2013-09-30       Impact factor: 5.048

Review 8.  Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?

Authors:  Malachy I Okeke; Arinze S Okoli; Diana Diaz; Collins Offor; Taiwo G Oludotun; Morten Tryland; Thomas Bøhn; Ugo Moens
Journal:  Viruses       Date:  2017-10-29       Impact factor: 5.048

9.  A Molecular Determinant of West Nile Virus Secretion and Morphology as a Target for Viral Attenuation.

Authors:  Justine Basset; Julien Burlaud-Gaillard; Maxence Feher; Philippe Roingeard; Félix A Rey; Nathalie Pardigon
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.